Cannabis could be effective for chronic lower back pain, phase III trial results suggest

VER-01, a full-spectrum extract of cannabis, was effective and well-tolerated for treating chronic lower back pain (CLBP), according to results of a phase III study. Publishing their findings in Nature Medicine on 29 September 2025, researchers analysed data from 820 adults with CLBP — 394 of whom took VER-01, with another 426 adults in the placebo […]

Publication Details

Journal
Pharmaceutical journal/˜The œpharmaceutical journal
Published
2025-01-01
DOI
https://doi.org/10.1211/pj.2025.1.377782
Primary Topic
Cannabis and Cannabinoid Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cannabis could be effective for chronic lower back pain, phase III trial results suggest

Pharmaceutical journal/˜The œpharmaceutical journal
Cannabis and Cannabinoid Research
article

Cannabis could be effective for chronic lower back pain, phase III trial results suggest

article en

Abstract

VER-01, a full-spectrum extract of cannabis, was effective and well-tolerated for treating chronic lower back pain (CLBP), according to results of a phase III study. Publishing their findings in Nature Medicine on 29 September 2025, researchers analysed data from 820 adults with CLBP — 394 of whom took VER-01, with another 426 adults in the placebo […]

Pharmaceutical journal/˜The œpharmaceutical journal
Openalex Percentile: Top 70%
Cannabis and Cannabinoid Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Cannabis could be effective for chronic lower back pain, phase III trial results suggest · Pharmaceutical journal/˜The œpharmaceutical journal (2025) | TGRS Research Map | TGRS